Anxiety and depression symptoms correlate with metabolic indicators in metabolic dysfunction-associated steatotic liver disease patients

doi:10.5498/wjp.v16.i8.117628

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 8

This Article

(14)

(16)

(0)

(24)

(279)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Psychiatry. Aug 19, 2026; 16(8): 117628
Published online Aug 19, 2026. doi: 10.5498/wjp.v16.i8.117628

Table 4 Correlation between Self-rating Anxiety Scale/Self-rating Depression Scale scores and metabolic indicators

Metabolic indicator	SAS score (r)	SDS score (r)
BMI	0.423^c	0.401^c
Waist circumference	0.387^c	0.369^c
TG	0.356^c	0.334^c
FBG	0.312^c	0.256^b
HbA1c	0.298^b	0.243^b
HDL-C	-0.267^b	-0.198^a
ALT	0.234^b	0.289^b
Hepatic fat content	0.341^c	0.318^c

^aP < 0.05.

^bP < 0.01.

^cP < 0.001.

SAS: Self-rating Anxiety Scale; SDS: Self-rating Depression Scale; BMI: Body mass index; FBG: Fasting blood glucose; HbA1c: Glycated hemoglobin; TG: Triglycerides; HDL-C: High-density lipoprotein cholesterol; ALT: Alanine aminotransferase.

Full Size Table

Citation: Wei ZW, Liu XD, Li DY, Cheng WL, Fu YP, Yang D. Anxiety and depression symptoms correlate with metabolic indicators in metabolic dysfunction-associated steatotic liver disease patients. World J Psychiatry 2026; 16(8): 117628
URL: https://www.wjgnet.com/2220-3206/full/v16/i8/117628.htm
DOI: https://dx.doi.org/10.5498/wjp.v16.i8.117628

Wei ZW, Liu XD, Li DY, Cheng WL, Fu YP, Yang D. Anxiety and depression symptoms correlate with metabolic indicators in metabolic dysfunction-associated steatotic liver disease patients. World J Psychiatry 2026; 16(8): 117628 [DOI: 10.5498/wjp.v16.i8.117628]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.